secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0000950170-25-085442
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Elected Class I directors R. Scott Struthers (69.6M for), Matthew K. Fust (67.6M for), and Rogério Vivaldi Coelho (68.9M for), each with ~3.6M broker non-votes.
- Ratified BDO USA as independent auditor for FY2025: 88.7M for, 129K against, 59.7K abstentions, no broker non-votes.
- Advisory vote approved named executive officer compensation: 82.7M for, 2.6M against, 20.9K abstentions, ~3.6M broker non-votes.
- Approximately 95% of outstanding shares (88.9M shares) were present or represented by proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000095017025085442/0000950170-25-085442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000095017025085442/crnx-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-085442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer